Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ahn-Gook Pharmaceutical Co Ltd
Gross Profit
Ahn-Gook Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
Gross Profit
₩200.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
9%
|
|
|
Yuhan Corp
KRX:000100
|
Gross Profit
₩729.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gross Profit
₩663.8B
|
CAGR 3-Years
47%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gross Profit
₩884.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
0%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gross Profit
₩109.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Gross Profit
₩52.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Ahn-Gook Pharmaceutical Co Ltd
Glance View
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.
See Also
What is Ahn-Gook Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
200.3B
KRW
Based on the financial report for Dec 31, 2025, Ahn-Gook Pharmaceutical Co Ltd's Gross Profit amounts to 200.3B KRW.
What is Ahn-Gook Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
9%
Over the last year, the Gross Profit growth was 19%. The average annual Gross Profit growth rates for Ahn-Gook Pharmaceutical Co Ltd have been 17% over the past three years , 19% over the past five years , and 9% over the past ten years .
